MFIM
DMTK

Mesirow Financial Investment Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Mesirow Financial Investment Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-26,087
Closed -$383K – 89
2022
Q1 		$383K Buy
+26,087
New +$349K 1.29% 42
2021
Q2 		– Sell
-645
Closed -$33K – 134
2021
Q1 		$33K Buy
645
+276
+75% +$14.4K 0.09% 77
2020
Q4 		$12K Buy
+369
New +$5.23K 0.04% 79

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Mesirow Financial Investment Management's DMTK Position: Q2 2022 in Review

Mesirow Financial Investment Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 26,087 shares — an estimated $383K sold.

Mesirow Financial Investment Management first reported a position in DMTK in Q4 2020 and held it in 3 quarters. The position peaked at $383K in Q1 2022. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

  • Mesirow Financial Investment Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 26,087 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $383K.
  • Mesirow Financial Investment Management first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Mesirow Financial Investment Management's DermTech, Inc. Common Stock position peaked at $383K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2022, filed 20 Jul 2022.